Uncategorized
Dirk Sauer, Ph.D. Joins Iconic Therapeutics' Board of Directors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Iconic Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to translating an understanding of Tissue Factor (TF) biology to new therapeutics for cancer, retinal disease and inflammation, today announced that Dirk Sauer, Ph.D., former Novartis Pharma AG’s Global Development Unit Head, Ophthalmology, has joined the company’s Board of Directors, bringing the current board membership to seven individuals. Dr. Sauer has been an Obser